Antibiotic-Induced Gut Toxicity Suppresses Immune Function
Lyme disease patients often become more debilitated after months of aggressive antibiotic therapy. Furthermore, prolonged antibiotic therapy suppresses the immune system in Chronic Lyme disease patients.
Lyme disease treatment consisting solely of antibiotic therapy can ultimately destroy the intestinal lining (where 70 percent of our immune system is located). Intestinal dysbiosis is the term used to describe an imbalance of intestinal organisms.
Prolonged antibiotic therapy ultimately kills our good intestinal bacteria. Lactobacillus is a healthy intestinal bacterium that produces lactic acid. Lactobacillus thereby ensures that the ph of our intestine remains more acidic disallowing the overgrowth of foreign invaders.
After prolonged antibiotic therapy, the intestinal ph becomes more alkaline allowing excessive overgrowth of pathogenic yeast and the following toxic bacterium: Klebsiella, Proteus, and Enterobacteriaceae. When Candida mycotoxins and bacterial endotoxins destroy the intestinal lining they also destroy our antibody factory, the Peyer’s patch which is located in our intestinal lining.
Destruction of the intestinal lining also causes severe malnutrition. Several of the essential amino acids are utilized to make natural killer cells. Thus the production of killer lymphocytes suffers from a malnourished state. With enough antibiotic-induced destruction of the intestinal lining, Lyme disease patients develop severe Leaky Gut Syndrome. Once Lyme patients develop significant Leaky Gut Syndrome, their Immune System will waste resources attacking undigested food particles that “leak” across the damaged intestinal lining into the bloodstream. Normally, these food particles are too large to cross over from the gut into the bloodstream.
We have correlated abnormal brain chemistry patterns with Lyme bio-marker CD 57 levels and the abnormalities seen on the brain scans of our Lyme patients. Our Chronic Lyme disease research has proven that antibiotic-induced changes in brain chemistry cause excessive electrical activity in two specific brain regions
When these brain regions become severely overactive, patients develop depression and a “worry-worry” type of anxiety. When Chronic Lyme disease patients develop an overactive deep limbic center, they suffer from depression, moodiness, negativity, irritability, hopelessness, excessive guilt, and social anxiety, and they become more easily offended.
When Chronic Lyme Disease patients develop an overactive anterior cingulate, they become more argumentative, more stubborn, and hyper-focused on the negative, and they develop obsessive-compulsive worry.
Antibiotic-Induced Gut Toxicity Causes Increased Brain Toxicity
After Chronic Lyme disease patients develop antibiotic-induced gut toxicity, yeast mycotoxins, and bacterial endotoxins migrate from the gut to the brain. These toxins are fatty in structure and deposit in the fattiest organ, our brain which is 60 percent fat.
These neurotoxins inflame the brain’s white matter, the insulation on brain neurons called myelin, adding to the cumulative level of neurotoxicity which is already significant from an accumulation of Lyme toxins in Lyme patients.
Antibiotic-induced neurotoxicity causes further suppression of the immune system by “shutting down” the electrical current in the brain. This is problematic because the brain’s electrical activity is responsible for stimulating cytokine activity. Cytokines are the chemical messengers that activate our natural killer cells.
When neurotoxins inflame the myelin sheath of brain neurons, they change the electromagnetic field surrounding the neuron; slowing the speed of the electrical impulse. By this mechanism, neurotoxins essentially suppress the brain’s electrical activity. In a healthy brain, the electrical current jumps over the myelin on brain neurons in a rapid fashion.
However, when the myelin sheath becomes infiltrated with fatty neurotoxins from the gut, in addition to toxins from the Lyme disease spirochete, it fails to effectively modulate immune function.
Should Antibiotics Be Used For Tickborne Disease ?
As my research at Sponaugle Wellness has shown, there is a place for the use of IV antibiotics in chronic Lyme patients once the body's immune function and natural killer power has been optimized.
When supplementing a healthy immune system, antibiotic therapy will provide a more “desired kill” of Borrelia spirochetes, and get patients home faster. It should be noted that withholding antibiotic therapy in Neurological Lyme Disease patients demonstrates a lack of judgment.
Biofilm Causes Antibiotic-Resistant Bacteria
While antibiotics can be very effective for killing Lyme Disease spirochetes and other bacteria in the “free-floating” bloodstream, antibiotics do not effectively penetrate the four-layer outer wall of Biofilm formations.
However, a small amount of antibiotics do get inside the Biofilm, but just enough to cause antibiotic resistance in Biofilm-protected bacteria.
Validating this concept are recent studies from the Center for Biofilm Engineering at Montana State University (MSU). The center’s research has proven that antibiotics do not effectively penetrate the protective Biofilm produced by Lyme disease spirochetes and other tick-borne microorganisms.
In fact, microbiologists at MSU have stated, “Antibiotic therapy not only fails to produce a bactericidal-kill in Biofilm-protected organisms, but antibiotic therapy given before Biofilm has been adequately dissolved also induces bacterial mutations, creating even more resistant phenotypes.”
According to the American Association of Quantum Medicine (AAQM), the more we use antibiotics to treat Biofilm-producing microorganisms, the stronger and more resistant they become. Furthermore, AAQM suggests that Biofilm-producing, drug-resistant microorganisms can only be conquered by enhancing the killing power of the immune system.
For this reason, the Sponaugle Wellness Team has spent years designing and improving Integrative Lyme Disease Treatment, which enhances immune function, even in the most immunocompromised Lyme disease patients.
As a result, our patients have no difficulty destroying Biofilm.
In addition to destroying Biofilm, we also optimize brain function, which subsequently optimizes the immune function, as the brain ultimately modulates and activates an immune function.